Nephrology Tweetbook: 2023

Friday, December 22, 2023

@NephRodby

http://twitter.com/NephRodby

@VelezNephHepato @rmohty The #KidneyWk post lecture Q&A was nothing but calm! https://bit.ly/3GT2lHN
— Roger Rodby (@NephRodby) Dec 23, 2023

https://twitter.com/NephRodby/status/1738355430621876499

Thursday, December 21, 2023

@hswapnil

http://twitter.com/hswapnil

via @brian_rifkin - slow or fast for hyponatremia correction? - AFib and anticoagulation (Renal AF, AXADIA published, SAFE-D at #kidneywk) #TopNephrology nominations
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Dec 21, 2023

https://twitter.com/hswapnil/status/1737913741864292412

@rheault_m

http://twitter.com/rheault_m

@hswapnil ✅ FDA Approval of new drugs for IgA nephropathy ✅Nephrology match results for peds and adult remain concerning. ✅ERA elects its first woman president. The last of the major nephrology societies to do so. ✅#NephJC podcast recording at #KidneyWk #TopNephrology
— Michelle Rheault (@rheault_m) Dec 21, 2023

https://twitter.com/rheault_m/status/1737904123956330745

@hswapnil

http://twitter.com/hswapnil

I will start with: - Renal denervation finally approved in the USA (both Medtronic and Otsuka/ReCor) - Endothelin antagonists advance (PROTECT/DUPLEX/PRECISION/ZENITH) - Inaxaplin in APOL1 - Freely Filtered simul-broadcast with @AmitXGarg #KidneyWk #TopNephrology nominations
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Dec 21, 2023

https://twitter.com/hswapnil/status/1737886439335927980

Wednesday, December 20, 2023

@ASNKidney

http://twitter.com/ASNKidney

Have you claimed your CE credits and MOC points for participating in #KidneyWk? Log in to the ASN eLearning Center now to complete the process. ⚠️ The deadline is today, Wednesday, December 20. ⚠️ Get Started: https://bit.ly/4762YIT https://bit.ly/488Fkgi
— American Society of Nephrology (@ASNKidney) Dec 20, 2023

https://twitter.com/ASNKidney/status/1737473237963989122

@JAMAInternalMed

http://twitter.com/JAMAInternalMed

Among transplant-eligible pts w/ advanced chronic kidney disease, this multicomponent intervention, which targeted many barriers to receiving a kidney transplant, did not significantly increase overall access to kidney transplantation. #KidneyWk @ASNKidney https://bit.ly/3vgeDYb
— JAMA Internal Medicine (@JAMAInternalMed) Dec 20, 2023

https://twitter.com/JAMAInternalMed/status/1737427627709718924

Tuesday, December 19, 2023

@ASNKidney

http://twitter.com/ASNKidney

🚨 Deadline Tomorrow 🚨 Only one day left to claim your CE credits and MOC points for participating in #KidneyWk before the deadline on Wednesday, December 20. Log in to the ASN eLearning Center today to get started. Log in: https://bit.ly/4762YIT https://bit.ly/3v7kwXI
— American Society of Nephrology (@ASNKidney) Dec 19, 2023

https://twitter.com/ASNKidney/status/1737201339212423192

Sunday, December 17, 2023

@kidney_boy

http://twitter.com/kidney_boy

At this year's @ASNKidney #KidneyWk there was a RCT of reactive ddavp versus proactive DDAVP (DDAVP Clamp) in severe hyponatremia If you went to Kidney Week you can see the presentation here: https://bit.ly/41sO3Hl https://bit.ly/471Ei4m
— Joel M. Topf, MD FACP (@kidney_boy) Dec 17, 2023

https://twitter.com/kidney_boy/status/1736447293962797304

Thursday, December 14, 2023

@ASNKidney

http://twitter.com/ASNKidney

Stay on top of the latest trends and advancements in nephrology with Kidney Week On-Demand. Access over 200 hours of educational content presented during ASN #KidneyWk 2023, including Early Program and Annual Meeting sessions. Get Started: https://bit.ly/4aivvh8 https://bit.ly/488tbrc
— American Society of Nephrology (@ASNKidney) Dec 14, 2023

https://twitter.com/ASNKidney/status/1735329111680106760

Wednesday, December 13, 2023

@jfnephlolz

http://twitter.com/jfnephlolz

@alportuk Sorry missed the change to vote YES! As @rheault_m so gloriously explained at #kidneywk this yr, early treatment with RAASi has very significant benefit to kidney health Knowing pathogenic variants are present early could help w/ monitoring proteinuria or starting RAASI at 1-2yo
— Tom Oates (@jfnephlolz) Dec 13, 2023

https://twitter.com/jfnephlolz/status/1734990139913293937

@Eledon_Pharma

http://twitter.com/Eledon_Pharma

It’s been a month since the @ASNKidney #KidneyWk meeting and our team and the #transplant community we serve are still feeling the excitement of the groundbreaking research presented across the field. Find a copy of our poster presentation here: https://bit.ly/4ak1Vb1 https://bit.ly/3tfL7kR
— Eledon Pharmaceuticals, Inc. (@Eledon_Pharma) Dec 13, 2023

https://twitter.com/Eledon_Pharma/status/1734965430295404649

Monday, December 11, 2023

@BEAT_CKD

http://twitter.com/BEAT_CKD

Thank you to our Kidney Bites Community for your engagement in 2023. We look forward to seeing you all next year!!!! #consumerengagement #BEAT-CKD #KidneyWk #KidneyBites #research https://bit.ly/3uZ68AY
— BEATCKD (@BEAT_CKD) Dec 12, 2023

https://twitter.com/BEAT_CKD/status/1734452981926641781

@VelezNephHepato

http://twitter.com/VelezNephHepato

7/7 @dani_nephron reported a large scale study confirming the entity at #KidneyWk 2022 https://bit.ly/41ksEQz @NephrosisMo @BhavnaBhasin1 @TJ_Wickman @SwethaKanduriMD @gautamphadke @runningbean26_2 @NephroRock @RossNesbit @IDdocAdi More to come in this condition in 2024…
— Juan Carlos Q Velez (@VelezNephHepato) Dec 11, 2023

https://twitter.com/VelezNephHepato/status/1734351902551240736

Friday, December 8, 2023

@ASNKidney

http://twitter.com/ASNKidney

In 2023, ASN experienced: ✔️ 800+ articles and podcasts from ASN publications. ✔️ 12,300+ participants in ASN #KidneyWk 2023. ✔️ 400+ hours of educational resources. ✔️ Six new Self-Assessment Programs. ✔️ Advocacy to improve kidney care. Join or renew: https://bit.ly/488usOP https://bit.ly/3RhyWvK
— American Society of Nephrology (@ASNKidney) Dec 8, 2023

https://twitter.com/ASNKidney/status/1733233796177154216

@OhioStateRheum

http://twitter.com/OhioStateRheum

The lovely Dr. Ganesan at the ASN Kidney Week 2023!! With her are nephrologists Anupam Agarwal, MD., Karl A. Nath, MD., and Vineeta Kumar, MD. #OSUWexMed #KidneyWk @OSUWexMed https://bit.ly/3GG5tGR
— Ohio State Rheumatology (@OhioStateRheum) Dec 8, 2023

https://twitter.com/OhioStateRheum/status/1733162109058396573

Wednesday, December 6, 2023

@NephJC

http://twitter.com/NephJC

If you couldn’t attend #KidneyWk, here is the recording from late breaking clinical trials session, where @HeerspinkHiddo presented ZENITH CKD #NephJC (start at 1hour 2min!) https://bit.ly/3RsD1i7
— Nephrology Journal Club (@NephJC) Dec 6, 2023

https://twitter.com/NephJC/status/1732435731824693561

@arvindcanchi

http://twitter.com/arvindcanchi

@NephJC Arvind Conjeevaram Bangalore based Nephrologist with no COI. Was at #KidneyWk when the Zibotentan presentation was done. Looking forward to see how it does further. #nephjc https://bit.ly/47GpQja
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Dec 6, 2023

https://twitter.com/arvindcanchi/status/1732423659455910163

Tuesday, December 5, 2023

@NephJC

http://twitter.com/NephJC

If you couldn’t attend #KidneyWk, here is the recording from late breaking clinical trials session, where @HeerspinkHiddo presented ZENITH CKD #NephJC (start at 1hour 2min!) https://bit.ly/3TtYsRt
— Nephrology Journal Club (@NephJC) Dec 6, 2023

https://twitter.com/NephJC/status/1732231888658391256

@NephroSeeker

http://twitter.com/NephroSeeker

@hswapnil @NephJC @hswapnil I so expected to drop this #kidneywk meta #nephjc https://bit.ly/4a100It
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Dec 6, 2023

https://twitter.com/NephroSeeker/status/1732228677214122078

@ckd_ce

http://twitter.com/ckd_ce

19) What an #ASN #KidneyWk for #IgAN enthusiasts (sorry that I didn’t mention all the IgAN data-there was just too much!). Let’s hope #ASN2024 is even better! https://bit.ly/3RtSjTR
— @CKD_ce (@ckd_ce) Dec 5, 2023

https://twitter.com/ckd_ce/status/1732016659756704222

@ckd_ce

http://twitter.com/ckd_ce

13a) The other major class of drugs currently being eval'd in #IgAN is the #complement inhibitors. ✔️out 🔓https://bit.ly/46IZbRA. At #KidneyWk we saw 1st data for the C5 inhibitor #Ravulizumabin IgAN, a drug we know well in atypical #HUS & #PNH: 🔓 https://bit.ly/480jjzJ
— @CKD_ce (@ckd_ce) Dec 5, 2023

https://twitter.com/ckd_ce/status/1732016630207488349

@ckd_ce

http://twitter.com/ckd_ce

12d) At #KidneyWk we also saw new clinical data from #NefIgArd: 🔓 https://bit.ly/3t0aK9f 🔓 https://bit.ly/46Mmium. https://bit.ly/46JS0IL
— @CKD_ce (@ckd_ce) Dec 5, 2023

https://twitter.com/ckd_ce/status/1732014061343137986

@ckd_ce

http://twitter.com/ckd_ce

2) @IgAN_JBarratt attended #KidneyWk 2023 and collected the best #IgAN highlights to share with our followers and learners here on @ckd_ce, your ONLY home for 🆓#renal CE/#CME delivered wholly on X!
— @CKD_ce (@ckd_ce) Dec 5, 2023

https://twitter.com/ckd_ce/status/1732014007488479729

Monday, December 4, 2023

@JonBKlein

http://twitter.com/JonBKlein

@gratefull080504 Goldie is Mike Solomonov's casual option. His other places are stellar IMO. @zahavrestaurant is a Beard Award winner. During #KidneyWk @Peptidome @TD_Cummins_PhD and I ate at Laser Wolf and it was outstanding. I make his lamb shoulder every Passover. https://t.co/yIDZvqqkX2
— Jon Klein PGY44 🇮🇱 (@JonBKlein) Dec 4, 2023

https://twitter.com/JonBKlein/status/1731682326340386942

Sunday, December 3, 2023

@JonBKlein

http://twitter.com/JonBKlein

I had lunch at this place last month during @ASNKidney #kidneywk . The lack of police presence is disturbing. https://bit.ly/3GynqXP
— Jon Klein PGY44 🇮🇱 (@JonBKlein) Dec 4, 2023

https://twitter.com/JonBKlein/status/1731463382774042869

Friday, December 1, 2023

@manasib33

http://twitter.com/manasib33

@scoca1 @YaleNephrology @unionleaguecafe @brewster_ursula @PKDSteve @RandyLucianoMD @anushreeshirali @NamrataKrishna3 @jmbnephdoc @JeffNeph @fperrywilson @YaleIMed @NFLFilms @ASN @nkf @Veenz80 Some one tweeted a quote from Dr. Perazella’s Narin’s award speech at #Kidneywk 2022 and it sits in front of me everyday! 3/3 Thank you Dr. Perazella! 🙏 https://bit.ly/480Tdg6
— Manasi Bapat MD, FASN, FNKF🇮🇳🇺🇸 (@manasib33) Dec 1, 2023

https://twitter.com/manasib33/status/1730724450306539826

@Maximal_Change

http://twitter.com/Maximal_Change

@AaronGoodman33 Bookmarking this thread for the next time #KidneyWk is in San Diego!
— Timothy Yau (@Maximal_Change) Dec 1, 2023

https://twitter.com/Maximal_Change/status/1730657553569230913

@Nephronline

http://twitter.com/Nephronline

🔍 Inflammatory mediators could provide a link between: 🔗 #Obesity and chronic #kidneydisease. 💡 That is according to data presented at #KidneyWk. https://bit.ly/3T2gr11
— Nephrology News & Issues (@Nephronline) Dec 1, 2023

https://twitter.com/Nephronline/status/1730654254979838228

@cbgitter

http://twitter.com/cbgitter

Thanks @PaulHannaMD for inviting me to share a med student’s perspective on #KidneyWk in @ASNKidney @KidneyNews ! https://bit.ly/3Rmtmto
— Chris Gitter (@cbgitter) Dec 1, 2023

https://twitter.com/cbgitter/status/1730631435386487092

@Christo51607547

http://twitter.com/Christo51607547

#KidneyWk
— DR.Christopher Jennings,MD (@Christo51607547) Dec 1, 2023

https://twitter.com/Christo51607547/status/1730607327852789951

@PaulHannaMD

http://twitter.com/PaulHannaMD

Check out trainees experience @ASNKidney #KidneyWk in this month’s issue @KidneyNews! @kdjhaveri @DukeKidney @MCW_Nephrology https://bit.ly/41jKGCR
— Paul E. Hanna, MD MSc (@PaulHannaMD) Dec 1, 2023

https://twitter.com/PaulHannaMD/status/1730598872378929378

Thursday, November 30, 2023

@NephRodby

http://twitter.com/NephRodby

@ssfarouk @ASNKidney @suresh_varsh94 @AbhinayaS15 @MadhusudanV92 @Doug_Rud @ISMMSKidney But did you get the question I submitted to the #KidneyWk FIT Bowl correct? The answer was 5-oxoproline or pyroglutamic acid.
— Roger Rodby (@NephRodby) Dec 1, 2023

https://twitter.com/NephRodby/status/1730441765843309008

@ssfarouk

http://twitter.com/ssfarouk

.@ASNKidney 2023 FIT Bowl Champions with their 🏆🥇🥇🥇 Congratulations @suresh_varsh94 @AbhinayaS15 @MadhusudanV92 @Doug_Rud @ISMMSKidney #Nephrology #KidneyWk https://bit.ly/3uMPyDZ
— Samira Farouk, MD, MSCR (@ssfarouk) Dec 1, 2023

https://twitter.com/ssfarouk/status/1730401604556181659

@Acute_Baxter_US

http://twitter.com/Acute_Baxter_US

Couldn’t make it to #KidneyWk ? No worries! We’d love to talk to you about the difference our TOTAL KIDNEY CARE SUPPORT could make to your practice! Let’s connect! 👉 https://bit.ly/3N6kB4f https://bit.ly/3SYe3bA
— Acute Therapies at Baxter - U.S. (@Acute_Baxter_US) Nov 30, 2023

https://twitter.com/Acute_Baxter_US/status/1730286829050458398

@Nephronline

http://twitter.com/Nephronline

🇦🇺 #Australia had the highest percentage of patients who chose home #dialysis, according to research from #KidneyWk. https://bit.ly/3Rn7Qoi
— Nephrology News & Issues (@Nephronline) Nov 30, 2023

https://twitter.com/Nephronline/status/1730270732309983243

@hswapnil

http://twitter.com/hswapnil

@poyanmehr @GrahamAbra @kidney_boy @HumphreysLab <my version of Tom Friedman talking to a cab driver> Speaking to a few US based fellows/younger nephrons at #KidneyWk - money seems to be the big factor (rheum/endo notwithstanding - perhaps its money + lifestyle: lifestyle hasn't changed in neph over the years, but money has)
— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Nov 30, 2023

https://twitter.com/hswapnil/status/1730232650399416691

@ardelyx

http://twitter.com/ardelyx

#TBT to an incredible #ASN #KidneyWk. Thanks to everyone who stopped by our booth, checked out our posters, attended our Exhibitor Spotlight and connected with our team. See you next year! #ArdelyxProud https://bit.ly/3N2ZJL9
— Ardelyx (@ardelyx) Nov 30, 2023

https://twitter.com/ardelyx/status/1730210228132602191

Wednesday, November 29, 2023

@NephJC

http://twitter.com/NephJC

Here is the live recorded @freelyfiltered episode, where the crew discussed about DUPLEX trial @rheault_m after opening #KidneyWK LBCT, didn’t considered herself too cool to come, pop up on the scen, then party with #NephJC people https://bit.ly/47yukIM
— Nephrology Journal Club (@NephJC) Nov 29, 2023

https://twitter.com/NephJC/status/1729899016832577849

@GlomCon

http://twitter.com/GlomCon

#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/3RnLYcB https://bit.ly/3uCXVCe https://bit.ly/47Srr5h
— GlomCon (@GlomCon) Nov 29, 2023

https://twitter.com/GlomCon/status/1729893163542941705

@GlomCon

http://twitter.com/GlomCon

#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/3RnLYcB https://bit.ly/47Srr5h
— GlomCon (@GlomCon) Nov 29, 2023

https://twitter.com/GlomCon/status/1729892863822229701

Tuesday, November 28, 2023

@NephJC

http://twitter.com/NephJC

Here is the live recorded @freelyfiltered episode, where the crew discussed about DUPLEX trial @rheault_m after opening #KidneyWK LBCT, didn’t consider herself too cool to come, pop up on the scene, then party with #NephJC people https://bit.ly/3SXbUgh
— Nephrology Journal Club (@NephJC) Nov 29, 2023

https://twitter.com/NephJC/status/1729695173485985849

@GlomCon

http://twitter.com/GlomCon

#KidneyWk GN pearl: ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population Median time to ESKD: 2.6 years After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯 https://bit.ly/46A4mDe https://bit.ly/3uC0YKP
— GlomCon (@GlomCon) Nov 28, 2023

https://twitter.com/GlomCon/status/1729634670453637624

@GlomCon

http://twitter.com/GlomCon

#KidneyWk GN pearl of the day: Corticosteroid Dose and Risk of Infection in Children and Adults with Glomerular Disease: An Analysis of the @CureGn Study Highlighting the importance of steroid-sparing regimens (?also infection prophylaxis?) https://bit.ly/3R7U5J0 https://bit.ly/3RlQ3xY https://bit.ly/3QYG8Ne
— GlomCon (@GlomCon) Nov 28, 2023

https://twitter.com/GlomCon/status/1729632548681105545

@VelezNephHepato

http://twitter.com/VelezNephHepato

If you miss this session during #KidneyWk because you were at the high-impact clinical trials, this is your chance now https://bit.ly/46FyrBf https://bit.ly/3SXsFrL
— Juan Carlos Q Velez (@VelezNephHepato) Nov 28, 2023

https://twitter.com/VelezNephHepato/status/1729521361683366322

Monday, November 27, 2023

@GlomCon

http://twitter.com/GlomCon

#KidneyWk pearl today: A @CureGn study on medication adherence. Perhaps one of the primary reasons for "treatment failure" or "treatment-refractory disease." Important insights into barriers to medication adherence reported by @JKrissberg et al. https://bit.ly/3MYv7KQ https://bit.ly/3GoEP5a https://bit.ly/3RjFA67
— GlomCon (@GlomCon) Nov 28, 2023

https://twitter.com/GlomCon/status/1729369762113937743

@tessa_novick

http://twitter.com/tessa_novick

5/ Among 32 dialysis patients with low SES, 44% reported unstable housing and 63% reported food insecurity. Dialysis led to and exacerbated social needs, and social needs fragmented care & increased stress. Findings reported at #KidneyWk 2023 @DrLizJacobs @DrDeidraCrews https://bit.ly/47ulr2P
— Tessa Novick, MD, MSW, MHS (@tessa_novick) Nov 27, 2023

https://twitter.com/tessa_novick/status/1729247912373481501

@ASNKidney

http://twitter.com/ASNKidney

📣 ASN Kidney Week On-Demand Now Available 📣 Access insights, lectures, and discussions from ASN #KidneyWk 2023 anytime, anywhere. Use your onsite access code or purchase the online product today! Get started: https://bit.ly/3QZ0plP https://bit.ly/40UKE3X
— American Society of Nephrology (@ASNKidney) Nov 27, 2023

https://twitter.com/ASNKidney/status/1729228765094355425

@DCHFT_Research

http://twitter.com/DCHFT_Research

Always great to see results being presented - the renal team are so pleased to have contributed to the #smileK study here @DCHFT. Thanks so much to all our patients that took part! #TeamDCH #BePartofResearch @mykidneysandme #ResearchActiveTrust #KidneyWk #kidneyresearch https://bit.ly/3sUGVa8
— DCHFT Research (@DCHFT_Research) Nov 27, 2023

https://twitter.com/DCHFT_Research/status/1729187354697687279

@somaticediting

http://twitter.com/somaticediting

ICYMI: #SCGE investigator @benofreedman accepted the @ASNKidney/@AHAScience 2023 Young Investigator Award at #KidneyWK 2023 👏👏 Listen to his address here ⬇️ https://bit.ly/49Tybl0
— Somatic Cell Genome Editing (SCGE) Outreach (@somaticediting) Nov 27, 2023

https://twitter.com/somaticediting/status/1729179385805390067

Sunday, November 26, 2023

@GlomCon

http://twitter.com/GlomCon

#KidneyWk pearls continued 👇 Lots of discussion around SGLT2i in IGAN. @AyoubIsabelle and @BradRovin provided a sneak preview of the PROTECT Open-Label Extension and SPARTACUS studies Spoiler alert 🚨 well tolerated + additional proteinuria reduction. More to come… https://bit.ly/46Aj9Ol https://bit.ly/40UBFzQ https://bit.ly/40UBGDU
— GlomCon (@GlomCon) Nov 27, 2023

https://twitter.com/GlomCon/status/1728936893738614793

@Stones__

http://twitter.com/Stones__

Thanks @GlomCon Credit to @Sorcha0792 @kiplet69 @THKC1 @Allysonegan1 #KidneyWk https://bit.ly/49QRJGO https://bit.ly/3GkijKZ
— Sinead Stoneman (@Stones__) Nov 26, 2023

https://twitter.com/Stones__/status/1728771255304945746

Saturday, November 25, 2023

@edgarvlermamd

http://twitter.com/edgarvlermamd

Management of hyponatremia in the patient with heart failure: Use of urine sodium (and urine potassium) to assess diuretic response from @FH_Verbrugge #Nephpearls #Cardiorenal #KidneyWk 👉 https://bit.ly/3Gh0HQ3 https://bit.ly/3GeK9rW
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) Nov 26, 2023

https://twitter.com/edgarvlermamd/status/1728597461432705510

@edgarvlermamd

http://twitter.com/edgarvlermamd

Using DDAVP in correction of hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Proactive strategy 📌 Reactive strategy 📌 Rescue strategy 👉 https://bit.ly/40TsHCG 👉 https://bit.ly/3T3IeOJ https://bit.ly/412oo8s
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) Nov 26, 2023

https://twitter.com/edgarvlermamd/status/1728593015147495560

@edgarvlermamd

http://twitter.com/edgarvlermamd

Treatment of Hyponatremia from @NephroMD #Nephpearls #KidneyWk 📌 Use of Hypertonic Saline (HTS) 📌 Management of severely symptomatic hyponatremia 📌 Pitfalls of correction 📌 Risk factors for rapid correction 👉 https://bit.ly/49TZdbX https://bit.ly/3MXPjfy
— Edgar V. Lerma 🇵🇭 (@edgarvlermamd) Nov 26, 2023

https://twitter.com/edgarvlermamd/status/1728588202687000967

@kidneyrebel

http://twitter.com/kidneyrebel

Listening to @nishakidneydoc and @nephroshah on how #KidneyWk set them on the path to #Nephrology. Bring your uber talented mentees to Kidney Week 2024! Also like hearing about a shift to how on home dialysis and a focus on early treatments. https://bit.ly/49W6p7M
— Kidney Rebel (@kidneyrebel) Nov 25, 2023

https://twitter.com/kidneyrebel/status/1728557966935167228

Friday, November 24, 2023

@GlomCon

http://twitter.com/GlomCon

#KidneyWk pearl An interesting report by @Stones__ and colleagues on ANCA-negative pauci-immune glomerulonephritis What explains the worse kidney function at the time of diagnosis - delay in diagnosis or more aggressive disease? https://bit.ly/3MXDXs9 https://bit.ly/47R48sD https://bit.ly/3SYZ3dC
— GlomCon (@GlomCon) Nov 25, 2023

https://twitter.com/GlomCon/status/1728246388600037726

@raad_chowdhury

http://twitter.com/raad_chowdhury

Listen to our ASN Podcast! Thank you @ASNKidney for inviting us to discuss science, healthcare equity, and the future of Nephrology! My voice on 4 hours of sleep with two different session to moderate but, we made it happen! #kidneywk @angieloboMD @docdeepakdc https://bit.ly/49VdPbl
— Raad Chowdhury, MD, FASN (@raad_chowdhury) Nov 25, 2023

https://twitter.com/raad_chowdhury/status/1728227650089718193

@kidneyrebel

http://twitter.com/kidneyrebel

Great to hear the #KidneyWk 2023 Podcast: Day 3 with @raad_chowdhury, @angieloboMD, and Deepak Chandramohan, MD discuss onconephrology, diversity and the Kidney STARS program among other things. Excited for the future! https://bit.ly/47pUldh
— Kidney Rebel (@kidneyrebel) Nov 24, 2023

https://twitter.com/kidneyrebel/status/1728147843561517385

Thursday, November 23, 2023

@CMClase

http://twitter.com/CMClase

Congratulations to authors of these articles selected to receive the 2023 AJKD Editors' Choice Award: https://bit.ly/3Rexc7C #KidneyWk Including: @PD_Perls #PD https://bit.ly/3QQxrVm
— Catherine Clase 😷🌈 (@CMClase) Nov 24, 2023

https://twitter.com/CMClase/status/1727891389004812536

@GlomCon

http://twitter.com/GlomCon

#KidneyWk self-promotion 🤫 A GlomCon Real-World Evidence Study The Natural History of Focal and Segmental Glomerulosclerosis (FSGS) A large-scale, multi-center, RWE study of patients in diverse healthcare settings with a tissue diagnosis of FSGS https://bit.ly/3R8QhrX https://bit.ly/47uCYbg https://bit.ly/3RdjIsU
— GlomCon (@GlomCon) Nov 23, 2023

https://twitter.com/GlomCon/status/1727828339321368618

@GlomCon

http://twitter.com/GlomCon

#KidneyWk pearls continues: Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with Focal Segmental Glomerulosclerosis (FSGS): Results from the Phase 3 DUPLEX Trial Presented by no one less than @rheault_m Watch here https://bit.ly/49T8txh https://bit.ly/49JGEHD https://bit.ly/49MMgAT
— GlomCon (@GlomCon) Nov 23, 2023

https://twitter.com/GlomCon/status/1727822600351703381

@arvindcanchi

http://twitter.com/arvindcanchi

@hswapnil @calvapo @jfnephlolz There are folks who've used it and written about it.. There was a poster at #KidneyWk https://bit.ly/46pIdHH
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 23, 2023

https://twitter.com/arvindcanchi/status/1727707966470824418

@r3pakistan

http://twitter.com/r3pakistan

Protecting your kidneys involves adopting healthy lifestyle habits that contribute to overall kidney function and well-being. #kidneyhealth #kidney #kidneywk #healthcare #Health #healthylifestyle #healthylife #Pakistan #Islamabad https://bit.ly/47MrD68
— R3 Stem Cell Pakistan (@r3pakistan) Nov 23, 2023

https://twitter.com/r3pakistan/status/1727619807661727800

Wednesday, November 22, 2023

@kdjhaveri

http://twitter.com/kdjhaveri

@gudnephron @PaulHannaMD @glom_busterMD @MCW_Nephrology @koyaljainMD Thanks!!, we had fun time doing it #kidneywk 2023 @ASNKidney
— Kenar Jhaveri (@kdjhaveri) Nov 23, 2023

https://twitter.com/kdjhaveri/status/1727497351617520102

@GlomCon

http://twitter.com/GlomCon

#KidneyWk had tons of exciting advances in glomerular diseases. Because it is more than one can absorb in a limited time, we have gone through all GN-related talks, presentations, and abstracts and will share some highlights here over the next few weeks here 🧵👇
— GlomCon (@GlomCon) Nov 22, 2023

https://twitter.com/GlomCon/status/1727374586235551842

@leicskidney

http://twitter.com/leicskidney

Part of the team had a chance to attend @ASNKidney #KidneyWk in Philadelphia and present some of our SMILE-K @mykidneysandme findings this month. Read more about #ASN23 on our website! @CourtneyJLight @RBillany @SocSciHealth @uniofleicester @LeicResearch https://bit.ly/3QQkDy3
— Leicester Kidney Lifestyle Team (@leicskidney) Nov 22, 2023

https://twitter.com/leicskidney/status/1727338853806288938

@nourynizar

http://twitter.com/nourynizar

I just published Revolutionize Prostate Health with Prostan Plus: Unleashing the Power of Nature for Optimal… ✅https://bit.ly/3R8GK4i #prostate #ProstateCancer #Cancer #MensHealth #healthcare #KidneyWk #Men #Over
— dani dani (@nourynizar) Nov 22, 2023

https://twitter.com/nourynizar/status/1727280542348124459

Tuesday, November 21, 2023

@AJKDonline

http://twitter.com/AJKDonline

Congratulations to authors of these articles selected to receive the 2023 AJKD Editors' Choice Award: https://bit.ly/3QIumI7 #KidneyWk https://bit.ly/3sJik86
— AJKD (@AJKDonline) Nov 21, 2023

https://twitter.com/AJKDonline/status/1727099623964074215

@ASNKidney

http://twitter.com/ASNKidney

Are you feeling nostalgic for #KidneyWk? Over 12,300 participants from more than 100 countries engaged in provocative discussions and reasserted their commitment to advancing kidney care. Don't forget to submit your suggestions for next year: https://bit.ly/49OWa4K https://bit.ly/3SMF9SU
— American Society of Nephrology (@ASNKidney) Nov 21, 2023

https://twitter.com/ASNKidney/status/1727073201535045984

@cavanaugh_do

http://twitter.com/cavanaugh_do

Did you love #kidneywk 2023 so much you already have ideas for next year? Me too - so share your ideas for GN sessions. We’d love to seem em. https://bit.ly/3MW13zo
— Corey Cavanaugh DO (@cavanaugh_do) Nov 21, 2023

https://twitter.com/cavanaugh_do/status/1727043265785176547

Monday, November 20, 2023

@arvindcanchi

http://twitter.com/arvindcanchi

Posters at #KidneyWk Tirzepatide demonstrated an increase in CysC-eGFR and reductions in UACR compared with placebo, suggesting renoprotective effects. These results warrant a long-term, prospective kidney outcome trial for people with obesity or overweight. SURMOUNT-1 Trial 👉… https://bit.ly/3QNIoH1 https://bit.ly/3R7pJar
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 21, 2023

https://twitter.com/arvindcanchi/status/1726799837797208490

@arvindcanchi

http://twitter.com/arvindcanchi

More posters at #KidneyWk "pooled individual-level data from 15 trials that included patients with eGFR<30 mL/min/1.73 m2 to examine the effect of ACEi/ARB use on the risk of the onset of KFRT, or secondarily, death using Cox models. Data from this pooled individual-level… https://bit.ly/47jsnj6 https://bit.ly/3szjGSV
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 21, 2023

https://twitter.com/arvindcanchi/status/1726792604535378370

@arvindcanchi

http://twitter.com/arvindcanchi

More posters at #KidneyWk "In participants with CKD and normal eGFR eating high acid-producing diets at baseline, dietary acid reduction over 5 years with either F+V or NaHCO3 yielded small but discernible improvements in acid-base status that might mediate slower CKD… https://bit.ly/49JU06u https://bit.ly/49WjldM
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 21, 2023

https://twitter.com/arvindcanchi/status/1726791316561096731

@kidneyrebel

http://twitter.com/kidneyrebel

Excited to listen to Dr. George Bakris and Dr. Duc Quach talking about increased emphasis at #KidneyWk on transplant, diversity, and under represented populations plus new innovations coming to the Nephrology toolkit! https://bit.ly/3MQAImh
— Kidney Rebel (@kidneyrebel) Nov 21, 2023

https://twitter.com/kidneyrebel/status/1726757670818894091

@kidneyrebel

http://twitter.com/kidneyrebel

Excited to listen to Dr. George Bakris and Dr. Duc Quach talking about increased emphasis at #KidneyWk on transplant, diversity, and under represented populations plus new innovations coming to the Nephrology toolkit! https://bit.ly/3MQAImh
— Kidney Rebel (@kidneyrebel) Nov 21, 2023

https://twitter.com/kidneyrebel/status/1726757287459484089

@benofreedman

http://twitter.com/benofreedman

My #KidneyWk young investigator address is online! It has 3 (nephron) segments: 1) Disease in a Dish 2) Regenerative Medicine 3) The Bigger Picture (how to support students and young investigators) Watch it here: https://bit.ly/47gGkhM Thank you again @ASNKidney @KidneyInCVD
— Beno Freedman (@benofreedman) Nov 20, 2023

https://twitter.com/benofreedman/status/1726646857903079782

Sunday, November 19, 2023

@kidneyrebel

http://twitter.com/kidneyrebel

Catching up on my #KidneyWk podcasts. Great to hear @kidney_boy and @jenniejlin’s enthusiasm for advances in the field. Thrilled to hear patient advocate Precious McCowan had served on the education committee, spoke, and moderated at Kidney Weeks. https://bit.ly/3MPLn0w
— Kidney Rebel (@kidneyrebel) Nov 19, 2023

https://twitter.com/kidneyrebel/status/1726302178158301425

@NephRodby

http://twitter.com/NephRodby

@threadreaderapp @kianboy @jmteakell @ASNKidney @amyaimei The Audience Question and Answer session of our (@amyaimei and me) "Calming the Waters" hypoNa session. Was quite the event. #KidneyWk https://bit.ly/46hNCAt
— Roger Rodby (@NephRodby) Nov 19, 2023

https://twitter.com/NephRodby/status/1726291226675269831

Saturday, November 18, 2023

@nephondemand

http://twitter.com/nephondemand

@drjosflynn @StotterMD @JonBKlein @ASNKidney @ASPNeph @Ped_Neph @mastodon @bluesky @Threads @instagram @hswapnil @rheault_m @kidney_boy @pedsnephrology 1/ Thanks Joe. Nephrology Twitter/X use has been decreasing for years. E.g., the amount of original content authored at the @ASNKidney meetings has fallen since 2015. Only 5.9 OTs authored per original author this #kidneywk. That drop is due to more than the ownership change. https://bit.ly/3R70N38
— Tejas Desai, MD MBA (@nephondemand) Nov 18, 2023

https://twitter.com/nephondemand/status/1725996108873109755

@Teknofiliac

http://twitter.com/Teknofiliac

@eric_weinhandl From #KidneyWk this year: (Eric, you probably have the full poster?) My gut feeling was that the increase in catheter rates was a pandemic effect. Check the figure below. Do you see when things started to get worse? https://bit.ly/3R5ry7U
— Wael Hussein (@Teknofiliac) Nov 18, 2023

https://twitter.com/Teknofiliac/status/1725922893534814223

Friday, November 17, 2023

@Nephron826

http://twitter.com/Nephron826

Thank you @msocoMD for this wonderful gift from #KidneyWk 2023 @ASNKidney . Goes perfectly well with my shorts (how else can you show the logo?) 😉 https://bit.ly/40QHfDm
— Rey Jaime Tan (@Nephron826) Nov 18, 2023

https://twitter.com/Nephron826/status/1725673450109632738

@WakeForestIM

http://twitter.com/WakeForestIM

Our section on nephrology's third invited presentation at #KidneyWk @ASNKidney featured Dr. Anthony Bleyer kicking off the workshop 'Integrating genetic testing into general nephrology care' to a packed audience! https://bit.ly/3R1vcQ6
— Wake Forest Department of Internal Medicine (@WakeForestIM) Nov 18, 2023

https://twitter.com/WakeForestIM/status/1725665873569140802

@WakeForestIM

http://twitter.com/WakeForestIM

Nephrology section chief, Dr. Barry Freedman, gave two invited talks at @ASNKidney #KidneyWk - APOL1 in Deceased Donor Kidney Transplantation - Anti-sense Oligonucleotide Therapy in APOL1 Nephropathy https://bit.ly/3R3Sx3J
— Wake Forest Department of Internal Medicine (@WakeForestIM) Nov 17, 2023

https://twitter.com/WakeForestIM/status/1725628879849840900

@WakeForestIM

http://twitter.com/WakeForestIM

Packed audience for our nephrologist @MarianaMurea 's presentation "Incremental Hemodialysis in Patients with Residual Kidney Function: Is it Possible?" at the Dosing Hemodialysis Clinical Practice Session at @ASNkidney #KidneyWk https://bit.ly/49J3u1M
— Wake Forest Department of Internal Medicine (@WakeForestIM) Nov 17, 2023

https://twitter.com/WakeForestIM/status/1725596164005982576

@goKDIGO

http://twitter.com/goKDIGO

KDIGO sat down with @BradRovin to get his insights on the changing landscape in managing and treating #glomerular diseases and to share highlights in #IgAN from ASN #KidneyWk 2023. Watch the video: https://bit.ly/3R57se8 "There is a lot of excitement about glomerular disease… https://bit.ly/3ulBgdo
— KDIGO (@goKDIGO) Nov 17, 2023

https://twitter.com/goKDIGO/status/1725591077573230782

Thursday, November 16, 2023

@DrDeidraCrews

http://twitter.com/DrDeidraCrews

@ASNKidney #KidneyWk 2023 was amazing, & we're already preparing for Kidney Week 2024! Thrilled Drs. Tamara Isakova @NU_Nephrology & Rasheed Gbadegesin (@GbadegesinLab @DukeKidney) will lead the Kidney Week Education Committee! Submit session ideas: https://bit.ly/47dIizF https://bit.ly/47frKY1
— Deidra Crews, MD, ScM, FASN, MACP (@DrDeidraCrews) Nov 16, 2023

https://twitter.com/DrDeidraCrews/status/1725265188948247023

@renalandurology

http://twitter.com/renalandurology

Patients with both cancer and diabetes who take sodium glucose cotransporter 2 inhibitors (SGLT2i) rather than glucagon-like peptide 1 receptor agonists (GLP-1 RA) have higher rates of certain adverse events, investigators reported at #KidneyWk. https://bit.ly/3G7U02w
— Renal & Urology News (@renalandurology) Nov 16, 2023

https://twitter.com/renalandurology/status/1725249636313477324

@renalandurology

http://twitter.com/renalandurology

Younger adults aged 18-39 years with subclinical reductions in #kidney function below their age-expected estimated glomerular filtration rate (eGFR) are at increased risk for major adverse cardiovascular events (MACE), investigators reported at #KidneyWk. https://bit.ly/3G3sC5P
— Renal & Urology News (@renalandurology) Nov 16, 2023

https://twitter.com/renalandurology/status/1725231517129994591

@poetricus2

http://twitter.com/poetricus2

Para aquellos que asistieron a #kidneywk este año, mostramos exactamente lo mismo en pacientes con enfermedad renal crónica, es decir, cada infección hacía que uno tuviera más probabilidades de contraer otra, incluso si estaba vacunado. Me alegro de que no estuviéramos alucinando https://bit.ly/46xt9rP
— antonio gonzalez (@poetricus2) Nov 16, 2023

https://twitter.com/poetricus2/status/1725148177458724867

Wednesday, November 15, 2023

@diariomedico

http://twitter.com/diariomedico

#KidneyWk | ➡ Modificar la #microbiota intestinal con antibióticos puede mejorar el daño renal hipertensivo. https://bit.ly/464u8zd
— Diario Médico (@diariomedico) Nov 16, 2023

https://twitter.com/diariomedico/status/1725043537186636127

@ChristosArgyrop

http://twitter.com/ChristosArgyrop

For those who attended #kidneywk this year, we showed the exact same thing in patients with Chronic Kidney Disease, i.e., each infection made one more likely to get another , even if one was vaccinated. I'm glad we were not hallucinating. Poster (this is me under the N95) https://bit.ly/49BJf6k https://bit.ly/49vxgXQ
— ChristosArgyropoulos MD, PhD FlozinatorInChief (@ChristosArgyrop) Nov 16, 2023

https://twitter.com/ChristosArgyrop/status/1724993884940337630

@jordy_bc

http://twitter.com/jordy_bc

Call for suggestions for ASN #KidneyWk 2024! Please submit suggestions for HTN & Cardiorenal topics you want to hear about and speakers you want to hear from at the link 👇! Excited to work with the amazing @annetkiraboc1 on HTN content this year! https://bit.ly/3QxyR6U
— Jordy Cohen, MD, MSCE (@jordy_bc) Nov 15, 2023

https://twitter.com/jordy_bc/status/1724835330925445300

@severencemacla1

http://twitter.com/severencemacla1

Has such a good time with @qasimbuttmd at @ASNKidney #kidneywk discussing how @deloreanai 's #renal #ai product is disrupting the #kidney and #dialysis market through our partnership with Innovative Renal Care!! A better way to better care!! https://bit.ly/3FYfbnM
— severence maclaughlin (@severencemacla1) Nov 15, 2023

https://twitter.com/severencemacla1/status/1724833652943544551

@NephJC

http://twitter.com/NephJC

Curious what’s next- on Nov 28& 29? If you read our newsletter you know for sure what plans we have after #Kidneywk! If still do not know what’s next on the list, let's say will DOUBLE (hint-wink) the fun and knowledge.. #NephJC
— Nephrology Journal Club (@NephJC) Nov 15, 2023

https://twitter.com/NephJC/status/1724828355118162341

@NephJC

http://twitter.com/NephJC

Well, we know it’s not as good as live recording, but look at how @hswapnil was for simultaneous podcast publishing. We know there were more happy people about, but all happened that fast and couldn’t take pics with all of them #Kidneywk #NephJC https://bit.ly/3FZ4KAf
— Nephrology Journal Club (@NephJC) Nov 15, 2023

https://twitter.com/NephJC/status/1724827348296519745

@avalere

http://twitter.com/avalere

Last week, #AvalereExperts attended @ASNKidney's #KidneyWk and presented on potential disparities between dual eligibles and non-dual eligibles' home #dialysis use. Read the findings here: https://bit.ly/3G24v7Q #Medicare #kidneyhealth #kidneydisease https://bit.ly/47h7RQm
— Avalere (@avalere) Nov 15, 2023

https://twitter.com/avalere/status/1724800793432510825

@VelezNephHepato

http://twitter.com/VelezNephHepato

When URINE a mood for a good day at work, ready to debate POLARIZED opinions. Showing off a generous gift from ⁦@jrseltzer⁩ during #KidneyWk #UrinarySediment #crystalluria 🔬 https://bit.ly/3QBhAtD
— Juan Carlos Q Velez (@VelezNephHepato) Nov 15, 2023

https://twitter.com/VelezNephHepato/status/1724800370885661147

Tuesday, November 14, 2023

@NephJC

http://twitter.com/NephJC

Curious what’s next- on Nov 28 & 29? If you read our newsletter you know for sure what plans we have after #Kidneywk! If still do not know what’s next on the list, let's say will DOUBLE (hint-wink) the fun and knowledge.. #NephJC
— Nephrology Journal Club (@NephJC) Nov 15, 2023

https://twitter.com/NephJC/status/1724624763556089990

@NephJC

http://twitter.com/NephJC

If you didn’t have time until now go listen to our podcast, which was on air perfectly synced with trial’s results, during late breaking clinical trials #KidneyWk https://bit.ly/47uXYOw https://bit.ly/3FZZ5df
— Nephrology Journal Club (@NephJC) Nov 15, 2023

https://twitter.com/NephJC/status/1724623505776574589

@anuja_java

http://twitter.com/anuja_java

@NephroSeeker @NephJC @WUNephrology Hi Cristina🥰. Been loving your #Kidneywk posts. It was wonderful to see you at the workshop.
— Anuja Java, MD (she/her) (@anuja_java) Nov 15, 2023

https://twitter.com/anuja_java/status/1724616536881586232

@NephroSeeker

http://twitter.com/NephroSeeker

Cristina Popa, here! 👋 Just a general nephrologist wanting to learn more about kidney transplant! Here or pod 1 #NSMC 🔥 Trying to adapt my schedule back to my timezone after #Kidneywk, but when #NephJC cannot sleep anyway Pic from the park across my hospital 2 days ago 🎨✍️ https://bit.ly/3FVzySJ
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 15, 2023

https://twitter.com/NephroSeeker/status/1724608457498571259

@jmteakell

http://twitter.com/jmteakell

Hello 👋 Jade Teakell here from @UTKidney in Houston. Excited to hear about ways we can improve the #KidneyTransplant ⚙️ process! Still thinking about these sparkly donuts from #KidneyWk… #NephJC No COI, and I’m not a transplant nephrologist fwiw https://bit.ly/3sq5yeB
— Jade Teakell (@jmteakell) Nov 15, 2023

https://twitter.com/jmteakell/status/1724608271292440937

@NephroSeeker

http://twitter.com/NephroSeeker

I hope to see as many of you as you were in #Kidneywk LBCT session tonight or tomorrow. The LBCT session was a rush, this is the afterparty where we can discuss more about waiting list donation and kidney transplant ⏰ Chat 1 at 9pm EST #NephJC https://bit.ly/3MJuncp
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 14, 2023

https://twitter.com/NephroSeeker/status/1724526990915407907

@renalandurology

http://twitter.com/renalandurology

Patients with ANCA-associated vasculitis renal involvement have increased plasma and urine levels of many proinflammatory cytokines, investigators reported at #KidneyWk. https://bit.ly/3QA6u8d
— Renal & Urology News (@renalandurology) Nov 14, 2023

https://twitter.com/renalandurology/status/1724513134541447607

@renalandurology

http://twitter.com/renalandurology

Patients with ANCA-associated vasculitis present with advanced #kidneydiseases, with differences between 2 major histologic subtypes of the rare condition, according to an analysis of real-world data presented at #KidneyWk. https://bit.ly/3G06tWk
— Renal & Urology News (@renalandurology) Nov 14, 2023

https://twitter.com/renalandurology/status/1724463959619613030

@EthosBioscience

http://twitter.com/EthosBioscience

If you missed us at @ASNKidney Week, see what’s new at Ethos! ConfirmCKD™ (Human kGuca2b) ELISA [RUO] is a sandwich enzyme #immunoassay for the quantitative measurement of hkGUCA2b in serum samples. https://bit.ly/3QBQwdI #worlddiabetesday #ckd #nephrology #elisa #kidneywk
— Ethos Biosciences - an Ott Scientific Company (@EthosBioscience) Nov 14, 2023

https://twitter.com/EthosBioscience/status/1724428218449744084

@heyscience_ai

http://twitter.com/heyscience_ai

@msc271 @jrseltzer @JasonProsek @AyoubIsabelle What an intriguing clinical case! Presentations like this that illuminate the nuances of diagnostic reasoning are so educational. We appreciate you and @jrseltzer generously sharing insights from #KidneyWk to advance medical knowledge. Looking forward to more fascinating cases!
— HeyScience (@heyscience_ai) Nov 14, 2023

https://twitter.com/heyscience_ai/status/1724365881277296717

Monday, November 13, 2023

@kidneyrebel

http://twitter.com/kidneyrebel

🙏 to the @ASNKidney, @MelissaW_ASN, and the family of Cele Fogarty for enabling people living with or caring for someone with kidney disease to attend #KidneyWk. I hope Cele's Champions develops a generation of kidney advocates who help create a world without kidney disease.
— Kidney Rebel (@kidneyrebel) Nov 14, 2023

https://twitter.com/kidneyrebel/status/1724285549811278214

@ChristosArgyrop

http://twitter.com/ChristosArgyrop

@jfnephlolz Glad you are sticking around even after #kidneywk
— ChristosArgyropoulos MD, PhD FlozinatorInChief (@ChristosArgyrop) Nov 14, 2023

https://twitter.com/ChristosArgyrop/status/1724225268217262371

@renalandurology

http://twitter.com/renalandurology

Hyperuricemia increases the risk of developing chronic #kidneydiseases (CKD), whether or not an individual is genetically predisposed to it, investigators reported at #KidneyWk. https://bit.ly/3sBUbjy
— Renal & Urology News (@renalandurology) Nov 13, 2023

https://twitter.com/renalandurology/status/1724107862857691281

@ASNKidney

http://twitter.com/ASNKidney

Janany Sabescumar, MD, an attending assistant professor at the University of Rochester, participated in her first #KidneyWk this year. She had a great experience connecting with old fellows, faculty members, and others from the industry. https://bit.ly/46bkjQi
— American Society of Nephrology (@ASNKidney) Nov 13, 2023

https://twitter.com/ASNKidney/status/1724095000793813220

@KeepinItRenal1

http://twitter.com/KeepinItRenal1

#thinkgenetic #NephTwitter #KidneyWk https://bit.ly/3QWeTnK
— Julianne Brown, MPH (@KeepinItRenal1) Nov 13, 2023

https://twitter.com/KeepinItRenal1/status/1724072612937015461

@collazor1

http://twitter.com/collazor1

19 weekend nephrology consults for the call after #kidneywk Great meeting,great science followed by a weekend plenty of clinical nephrology.😂😂The best of the two worlds.👌
— Dr.Roberto Collazo-Maldonado (@collazor1) Nov 13, 2023

https://twitter.com/collazor1/status/1724068068895150187

@arvindcanchi

http://twitter.com/arvindcanchi

Interesting Poster that I saw on PreDiabetes (PDM) and #ckd incidence (at #KidneyWk) Persons with PDM (N=256,829) were 55% women and 56±15 years old. After a median follow-up of 2.6 years, CKD was identified in 7%. Of these, 43% had an eGFR <60 mL/min/1.73 m2. Standardized… https://bit.ly/3udotJZ https://bit.ly/471Ipy1
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 13, 2023

https://twitter.com/arvindcanchi/status/1724047967135715639

@arvindcanchi

http://twitter.com/arvindcanchi

Yes, Christos makes a good point on masking. Met him at #KidneyWk recently where he was masked. I wear the n95 in hospitals and ICUs still, may need to extend it to other places perhaps 🤔 https://bit.ly/3QVjYg5 https://bit.ly/3FUJknQ
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 13, 2023

https://twitter.com/arvindcanchi/status/1724030904430182769

Sunday, November 12, 2023

@annetkiraboc1

http://twitter.com/annetkiraboc1

@Dan_Batlle @FZMarques I missed you at #kidneywk @Dan_Batlle! It came to my attention that you were in attendance.
— Annet Kirabo D.V.M., M.Sc., Ph.D., F.A.H.A. (@annetkiraboc1) Nov 12, 2023

https://twitter.com/annetkiraboc1/status/1723830702150438987

Saturday, November 11, 2023

@KidneyWars

http://twitter.com/KidneyWars

@kidneyrebel It was amazing to meet you! #KidneyWk is pure magic, even though it feels I missed EVERYTHING!
— NoWars (@KidneyWars) Nov 12, 2023

https://twitter.com/KidneyWars/status/1723553812709802453

@kidneyrebel

http://twitter.com/kidneyrebel

My first #KidneyWk was amazing. Met so many wonderful people, went to so many great sessions, and attended awesome social events. And probably only made to a third of what I wanted to. Next year’s Kidney Week can’t arrive soon enough.
— Kidney Rebel (@kidneyrebel) Nov 12, 2023

https://twitter.com/kidneyrebel/status/1723538665194893718

@nephondemand

http://twitter.com/nephondemand

@gunnar_heine Indeed. This one trial doesn't knock SGLT2i in my mind. As a physician community, however, we need to know the limits of this class of agents. I'm glad we are uncovering those limits sooner rather than later. #AHA23 Enjoy Philly. We were there last week for #KidneyWk.
— Tejas Desai, MD MBA (@nephondemand) Nov 11, 2023

https://twitter.com/nephondemand/status/1723469278014267535

@nephondemand

http://twitter.com/nephondemand

I note that #AHA23 followed #KidneyWk 2023 in Philly. The latter was a 4-day meeting with the bulk of ed material on R,F, and S. The former is a 4-day meeting with the bulk of ed material on F,S, and U. Should #KidneyWk present more ed material on U and attract more attendees? https://bit.ly/46gco3T
— Tejas Desai, MD MBA (@nephondemand) Nov 11, 2023

https://twitter.com/nephondemand/status/1723466536394834106

@IcahnMountSinai

http://twitter.com/IcahnMountSinai

Congratulations to the @ISMMSKidney Fellows on being the winners of the @ASNKidney FIT Bowl 2023 at #KidneyWk, they all worked hard to showcase their knowledge of nephrology. #Nephrology https://bit.ly/3FSKU9U
— Icahn School of Medicine at Mount Sinai (@IcahnMountSinai) Nov 11, 2023

https://twitter.com/IcahnMountSinai/status/1723435700450689290

@GrahamAbra

http://twitter.com/GrahamAbra

The question that was often asked and indeed, was asked by @wilkiemart during the #KidneyWk oral abstract session is why included death in the SDR in addition to transfer to HD I don’t believe in therapeutic nihilism and deaths can be a signal of poor care processes
— Graham Abra, MD (@GrahamAbra) Nov 11, 2023

https://twitter.com/GrahamAbra/status/1723387869048488269

@Teknofiliac

http://twitter.com/Teknofiliac

@eric_weinhandl takes the stage for an oral presentation, moderated by @GrahamAbra and @nupur_nephron, to reveal a new metric: 💥The Standardized Discontinuation Ratio 💥 This is a novel measure for real-time monitoring of #HomeDialysis discontinuation. 🧵 #ASN #KidneyWk https://bit.ly/46c0Q1V
— Wael Hussein (@Teknofiliac) Nov 11, 2023

https://twitter.com/Teknofiliac/status/1723366782575010111

Friday, November 10, 2023

@NephroSeeker

http://twitter.com/NephroSeeker

3/ If you don't know what PIEZOs are, don't worry, neither did many of us, until 1 wk ago! You'd probably ❤️ hypothesis: our kidneys use same molecule to sense pressure as your fingertips do to sense touch! The amazing #kidneywk plenary lecture @ardemp https://bit.ly/3QTalOQ
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 10, 2023

https://twitter.com/NephroSeeker/status/1723119730116919352

@NephroSeeker

http://twitter.com/NephroSeeker

2/ Maybe an undercover nephrologist, or maybe empathizing with nephrology cause, because he understands it so well, @ardemp explained to Parta Hatamizadeh how "heart is a big muscle" and it does not have PIEZO channels (pls correct me if wrongly understood😃) #KidneyWk https://bit.ly/49q3HHj
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 10, 2023

https://twitter.com/NephroSeeker/status/1723119727726211156

@NephroSeeker

http://twitter.com/NephroSeeker

Sadly, there is not any special section in the CV for once-in-a-lifetime thing like this. But the heart knows better in these cases. A selfie with a @ardemp fab Nobel laureate who really gets the nephrologists, and probably the single one who will ever DM me on Twitter #KidneyWk https://bit.ly/3uaNUMm
— Cristina Popa @NephroSeeker@med-mastodon.com (@NephroSeeker) Nov 10, 2023

https://twitter.com/NephroSeeker/status/1723119725033517406

@renalandurology

http://twitter.com/renalandurology

Adults with higher urinary molybdenum levels are less likely to be diagnosed with hyperuricemia and gout, investigators reported at #KidneyWk. https://bit.ly/468DFW7
— Renal & Urology News (@renalandurology) Nov 10, 2023

https://twitter.com/renalandurology/status/1723056434840060316

@SarahSanghavi

http://twitter.com/SarahSanghavi

Interesting article showing that CF carrier status is associated with a higher risk of volume depletion and hypokalemia compared with controls. Reminds me of a case presented at #KidneyWk from @Rush_Nephrology. https://bit.ly/4685IoC
— Sarah Sanghavi (@SarahSanghavi) Nov 10, 2023

https://twitter.com/SarahSanghavi/status/1723014305103397235

@TravereRare

http://twitter.com/TravereRare

Thank you to everyone who joined us at @ASNKidney #ASN23 #KidneyWk and who share our commitment to bringing innovation to people living with #IgAN and #FSGS. We are grateful to all those who contributed to another thought-provoking meeting on advances in #RareKidneyDisease (RKD). https://bit.ly/3QyBR31
— Travere Therapeutics (@TravereRare) Nov 10, 2023

https://twitter.com/TravereRare/status/1723010913349906511

@pittkidneyctr

http://twitter.com/pittkidneyctr

Love seeing our team together for @ASNKidney #KidneyWk ! https://bit.ly/3SD6Tt0
— Univ of Pitt Center for Kidney Research (@pittkidneyctr) Nov 10, 2023

https://twitter.com/pittkidneyctr/status/1722986030192624048

@dra_miliflores

http://twitter.com/dra_miliflores

Novedades #enfermedadrenal #sparsentan vs #irbesartan ⛔️Sin #RAAS ⬇️Remisión proteinuria ✅ ➡️Retraso en la necesidad TSR DUPLEX phase 3 trial 👏@rheault_m @NEJM #KidneyWk #nefroneando #ISNyoung #ThisIsISN https://bit.ly/49x0t4Q https://bit.ly/3ss04zQ
— Milagros Flores (@dra_miliflores) Nov 10, 2023

https://twitter.com/dra_miliflores/status/1722977420360487163

@PamelaVasquez88

http://twitter.com/PamelaVasquez88

More #KidneyWk memories! @PalNeph_NM @NephCrit_NM @Nephr0s @ChristosArgyrop @captainchloride Opeyemi Olabisi https://bit.ly/4773ffs
— Pamela Vasquez (@PamelaVasquez88) Nov 10, 2023

https://twitter.com/PamelaVasquez88/status/1722962609056399680

@PamelaVasquez88

http://twitter.com/PamelaVasquez88

More #KidneyWk memories! https://bit.ly/3FTO5yc
— Pamela Vasquez (@PamelaVasquez88) Nov 10, 2023

https://twitter.com/PamelaVasquez88/status/1722955759548338399

Thursday, November 9, 2023

@azzilab

http://twitter.com/azzilab

🌟 Reflecting on an inspiring week @ASNKidney #kidneywk 2023! 🌟 We witnessed the incredible work of our own #womeninnephrology. Very grateful to ASN for the invitation to present our work. https://bit.ly/3SztQxm
— J.Azzilab (@azzilab) Nov 9, 2023

https://twitter.com/azzilab/status/1722734649590325541

@WUNephrology

http://twitter.com/WUNephrology

Sharing old memories and making new ones, current and former members of the division, with family and friends, attended @WUNephrology's Alumni and Friends Reception at @ASNKidney #KidneyWk 2023. See slideshow in link. https://bit.ly/40t2F9n
— WU in STL Nephrology (@WUNephrology) Nov 9, 2023

https://twitter.com/WUNephrology/status/1722640983601369500

@GESGlobal

http://twitter.com/GESGlobal

From across the globe, 12,000+ kidney professionals gathered for @ASNKidney Kidney Week 2023 held at the @PAConvention! 🌍💼✨ @GES_EMEA I @GESMiddleEast I @GES_Canada #KidneyWk #visitphilly #conventioncenters #exhibitions #tradeshows #growtogether https://bit.ly/3svaz5t https://bit.ly/3SzCkEx
— GES (@GESGlobal) Nov 9, 2023

https://twitter.com/GESGlobal/status/1722630121276731703

@LoriBaker444

http://twitter.com/LoriBaker444

Still catching up on the plethora of data presented at #KidneyWk for #IgAN and Glomerular Diseases as a whole. The poster rows were packed Saturday! Had to fight the crowd to get a minute w/ @BradRovin! https://bit.ly/3FQB8VJ
— Lori Baker (@LoriBaker444) Nov 9, 2023

https://twitter.com/LoriBaker444/status/1722608847049859222

@HCPLiveNews

http://twitter.com/HCPLiveNews

ICYMI: As part of our #KidneyWk coverage, we are spotlighting a select group of abstracts from the meeting highlighting racial disparities in the world of #nephrology Learn more: https://bit.ly/47pmRv3
— HCPLive (@HCPLiveNews) Nov 9, 2023

https://twitter.com/HCPLiveNews/status/1722599924460568704

@ASPNeph

http://twitter.com/ASPNeph

Patient navigator intervention seen as safe, useful for children newly diagnosed with #CKD https://bit.ly/3Qvg38q @GoHealio presented at #KidneyWk
— American Society of Pediatric Nephrology (@ASPNeph) Nov 9, 2023

https://twitter.com/ASPNeph/status/1722584901151572121

Wednesday, November 8, 2023

@arvindcanchi

http://twitter.com/arvindcanchi

Met with @kidney_boy on the last day of #KidneyWk. Thanks to @NephroSeeker for the pic! Also note @brian_rifkin in the picture. https://bit.ly/47hJkKE
— Arvind Canchi (Conjeevaram)🇮🇳 (@arvindcanchi) Nov 9, 2023

https://twitter.com/arvindcanchi/status/1722444116057797040

@JWatch

http://twitter.com/JWatch

In NEJM Group's final report on #KidneyWk, our clinician-guides, @MegSise and @OpeyemiOlabisi8, share key takeaways from the nephrology meeting and how these findings might change their practice. https://bit.ly/3Qu02Q8 https://bit.ly/40tQ99o
— NEJM Journal Watch (@JWatch) Nov 9, 2023

https://twitter.com/JWatch/status/1722409297068556528

@renalandurology

http://twitter.com/renalandurology

Zibotentan, a selective endothelin A receptor antagonist, may further reduce albuminuria in patients with chronic #kidneydiseases (CKD) when added to SGLT2 inhibitor therapy, investigators reported at #KidneyWk. https://bit.ly/49stfTV
— Renal & Urology News (@renalandurology) Nov 8, 2023

https://twitter.com/renalandurology/status/1722302970010747251

@CarelonResearch

http://twitter.com/CarelonResearch

In collaboration with @boehringerus, we conducted the first large-scale U.S. validation of a new AI-driven tool to predict risk of chronic kidney disease progression. Learn more: https://t.co/WtScZRunWG #KidneyWk #CKD #news #PressRelease https://bit.ly/4617Uy1
— Carelon Research (@CarelonResearch) Nov 8, 2023

https://twitter.com/CarelonResearch/status/1722297937030762877

@UNMCkidney

http://twitter.com/UNMCkidney

Amongst the best parts of #KidneyWk for our team was that Dr. Wekesa's parents came to Philadelphia to see her present!!! https://bit.ly/465irbt https://bit.ly/47pgKa8
— UNMC Kidney (@UNMCkidney) Nov 8, 2023

https://twitter.com/UNMCkidney/status/1722297931519119762

@KPMProject

http://twitter.com/KPMProject

And the votes are in...the unanimous decision was that #KidneyWk 2023 was a blast! 🎉 Thank you to all who featured #KPMP data and congratulations to all presenters and award recipients! It's definitely safe to say that we are already counting down the days until next year https://bit.ly/47sAk5n
— Kidney Precision Medicine Project (@KPMProject) Nov 8, 2023

https://twitter.com/KPMProject/status/1722284975918063753

@ISGDtweets

http://twitter.com/ISGDtweets

Our reflections on #KidneyWk and the vibrant glomerular community there: https://bit.ly/3MBunLf
— International Society of Glomerular Disease (@ISGDtweets) Nov 8, 2023

https://twitter.com/ISGDtweets/status/1722270859992469806

@ASPNeph

http://twitter.com/ASPNeph

Study: Chimerism seen as successful in living-related kidney donors https://bit.ly/3FT8JOZ @GoHealio presented at #KidneyWk #Transplant
— American Society of Pediatric Nephrology (@ASPNeph) Nov 8, 2023

https://twitter.com/ASPNeph/status/1722267884431548478

@HCPLiveNews

http://twitter.com/HCPLiveNews

Catch up on anything you might have missed from #KidneyWk by heading over to our conference coverage page: https://bit.ly/49hZoh3
— HCPLive (@HCPLiveNews) Nov 8, 2023

https://twitter.com/HCPLiveNews/status/1722237542446367054

@SannaCherchiLab

http://twitter.com/SannaCherchiLab

And no better way to close our posts (delayed) from #KidneyWk with a night out with the gang! Thank you guys!! @JMartinoActual @GuptaYask @tzeyinlim #FSGS #CAKUT #beer #genetics #nephrology #pediatrics #nephroticsyndrome https://bit.ly/3SCCr2p
— SSC_Lab 🧬 (@SannaCherchiLab) Nov 8, 2023

https://twitter.com/SannaCherchiLab/status/1722232335175930236

@ATCC_LGC

http://twitter.com/ATCC_LGC

We hope you had a fantastic time presenting at @ASNKidney #KidneyWk, @benofreedman! Its so exciting to see #Organoids getting the spotlight at fantastic events like this 🙌 #OrganoidPower https://bit.ly/47lDXK5
— LGC in partnership with ATCC (@ATCC_LGC) Nov 8, 2023

https://twitter.com/ATCC_LGC/status/1722223211361026399

Tuesday, November 7, 2023

@IcahnMountSinai

http://twitter.com/IcahnMountSinai

Congratulations to our @ISMMSKidney fellows for presenting their work at #KidneyWk! @DureyaSyed @Doug_Rud @RahulM_MD @DOMSinaiNYC #Nephrology https://bit.ly/47mmBNf
— Icahn School of Medicine at Mount Sinai (@IcahnMountSinai) Nov 7, 2023

https://twitter.com/IcahnMountSinai/status/1721936388268929216

@renalandurology

http://twitter.com/renalandurology

Oral urea effectively treats hyponatremia in patients with the syndrome of inappropriate antidiuresis (SIAD) who fail to respond to fluid restriction, investigators reported at #KidneyWk. https://bit.ly/3QPlbFu
— Renal & Urology News (@renalandurology) Nov 7, 2023

https://twitter.com/renalandurology/status/1721936051977990516

@UNMCkidney

http://twitter.com/UNMCkidney

Dr. Wekesa of @UNMCIMResidency presented her oral abstract "Outcome of OPTN Policy Allowing for Waiting Time Modification for Candidates Affected by Race-Inclusive eGFR Calculations" during the "Top Trainee" Session at @ASNKidney #KidneyWk! https://bit.ly/3smL6Ly
— UNMC Kidney (@UNMCkidney) Nov 7, 2023

https://twitter.com/UNMCkidney/status/1721935543410254192

@ISMMSKidney

http://twitter.com/ISMMSKidney

Congratulations to our fellows! #KidneyWk #Nephrology https://bit.ly/40qaHQk
— Barbara T. Murphy Mount Sinai Div. of Nephrology (@ISMMSKidney) Nov 7, 2023

https://twitter.com/ISMMSKidney/status/1721931435458654249

@IcahnMountSinai

http://twitter.com/IcahnMountSinai

Congratulations to our @ISMMSKidney #KidneyWk Fellows-In-Training Bowl Champions! 🏆 @MadhusudanV92 @suresh_varsh94 @AbhinayaS15 @Doug_Rud @DOMSinaiNYC #Nephrology #MedEd https://bit.ly/47lK2GB
— Icahn School of Medicine at Mount Sinai (@IcahnMountSinai) Nov 7, 2023

https://twitter.com/IcahnMountSinai/status/1721925293785448681

@AstraZenecaUS

http://twitter.com/AstraZenecaUS

Last week, we presented real-world evidence during @ASNKidney #KidneyWk. It's crucial to continue educating communities about the risks patients face from the connectivity of renal disease and cardiovascular events. @ASNKidney #ASN2023 https://bit.ly/468mP9M
— AstraZenecaUS (@AstraZenecaUS) Nov 7, 2023

https://twitter.com/AstraZenecaUS/status/1721924239916253211

@renalandurology

http://twitter.com/renalandurology

The risks for cardiovascular and renal events do not differ between new febuxostat and allopurinol users who have stage 3 or higher chronic #kidneydiseases (CKD) not on dialysis, investigators reported at #KidneyWk. https://bit.ly/40sCuQ4
— Renal & Urology News (@renalandurology) Nov 7, 2023

https://twitter.com/renalandurology/status/1721918778773045568

@jmteakell

http://twitter.com/jmteakell

Brought some coffee beans home from #KidneyWk #MedGrind @OldCityCoffee ☕️ https://bit.ly/49pGogE
— Jade Teakell (@jmteakell) Nov 7, 2023

https://twitter.com/jmteakell/status/1721883562302226633

@KidneyFund

http://twitter.com/KidneyFund

@jbbayton @ASNKidney @AKF_Advocacy Thank you so much for stopping by our booth, John! It's always a pleasure seeing and connecting with you. #KidneyWk
— American Kidney Fund (@KidneyFund) Nov 7, 2023

https://twitter.com/KidneyFund/status/1721882533540118565

@ChristosArgyrop

http://twitter.com/ChristosArgyrop

@kidney_boy Another way to look at this is tweet/participant -> less engagement. It would be interesting to see how many ppl actually attended #KidneyWk and thus generated primary content. Note that we are back to 2015. Twitter was dying back then & got 2 boosts afterwards ie Trump & COVID
— ChristosArgyropoulos MD, PhD FlozinatorInChief (@ChristosArgyrop) Nov 7, 2023

https://twitter.com/ChristosArgyrop/status/1721877999711047697